Please use this identifier to cite or link to this item:
http://10.1.7.192:80/jspui/handle/123456789/9650
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Singh, Aditi A. | - |
dc.date.accessioned | 2021-01-28T10:31:34Z | - |
dc.date.available | 2021-01-28T10:31:34Z | - |
dc.date.issued | 2020-05 | - |
dc.identifier.uri | http://10.1.7.192:80/jspui/handle/123456789/9650 | - |
dc.description | Guided by Dr. Vivek Vyas | en_US |
dc.publisher | Institute of Pharmacy, Nirma University, A'bad | en_US |
dc.relation.ispartofseries | PPR00934; | - |
dc.subject | PPR00934 | en_US |
dc.subject | Pharmaceutical Chemistry | en_US |
dc.subject | Biosimilars | en_US |
dc.subject | Regulatory Requirement | en_US |
dc.subject | Developed Countries | en_US |
dc.subject | USA | en_US |
dc.subject | Europe | en_US |
dc.subject | Developing Countries | en_US |
dc.subject | India | en_US |
dc.title | Regulatory Requirements for Biosimilars in Developed (USA and Europe) and Developing (India) Countries | en_US |
dc.type | Project Report | en_US |
Appears in Collections: | B. Pharm Project Reports |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PPR00934.pdf | PPR00934 | 3.21 MB | Adobe PDF | ![]() View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.